Clinical Trials Browser

AZD 6244 × Tumor-Agnostic × 1 year × Clear all

NCT02813135 2026-01-16

ESMART

Phase 1/2 Recruiting

Neoplasms

NCT00463814 2025-11-13

AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies

Phase 1 Active not recruiting

Neoplasms